Enanta Pharma slides after $50 mln stock offering unveiled

Enanta Pharmaceuticals

30/09/2025 21:59

** Shares of Enanta Pharmaceuticals ENTA.O down 8% at $11.01 post-market after biotech firm launches follow-on

    ** Watertown, Massachusetts-based ENTA commences $50 mln stock offering

    ** JP Morgan, Jefferies and Evercore are joint bookrunners

** On Mon, ENTA shares surged 92% to close at $15.16 after co said its RSV treatment significantly quickened recovery in mid-stage study

    ** On Tues, stock ended down 21% at $11.97

    ** ENTA intends to use net offering proceeds to fund clinical trials, R&D, among other purposes, per the prospectus

** It has ~21.4 mln shares outstanding for roughly $256 mln market cap through Tues

    ** 5 of 7 analysts rate the stock "strong buy" or "buy" and 2 rate "hold"; median PT is $20, according to LSEG data

(Lance Tupper is a Reuters market analyst. The views expressed are his own)

((lance.tupper@tr.com 1-646-279-6380))